Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
22.86
+0.39 (1.74%)
At close: Nov 7, 2025, 4:00 PM EST
22.78
-0.08 (-0.35%)
After-hours: Nov 7, 2025, 7:41 PM EST
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.31 billion as of November 7, 2025. Its market cap has increased by 98.09% in one year.
Market Cap
1.31B
Enterprise Value
981.86M
1-Year Change
98.09%
Ranking
Category
Stock Price
$22.86
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.31B, an increase of 62.31%. That is a compound annual growth rate of 7.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 1.28B | 119.68% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 849.94B |
| Johnson & Johnson | 448.02B |
| AbbVie | 382.36B |
| UnitedHealth Group | 296.36B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.00B |
| Novo Nordisk | 215.64B |